Steven A. Grossman, JD

Steven A. Grossman, JD, is a regulatory and policy consultant whose experiences cross all areas of FDA. In addition to being a senior advisor to Kinexum, he has his own small consulting group, HPS Group, LLC. He is widely recognized as a subject-matter expert on FDA.

Prior to becoming a consultant, Mr. Grossman spent a decade in public service. He was the Health Staff Director of the Senate Labor and Human Resources Committee (now HELP). In that capacity, he was one of the chief Senate negotiators for the Orphan Drug Act (ODA) and for the Drug Price Competition and Patent Term Restoration Act (known as Hatch-Waxman).

After leaving the Senate, Mr. Grossman was a Deputy Assistant Secretary for Health at HHS. In that capacity, he was responsible for policy, planning and evaluation for the seven Public Health Service agencies.

Mr. Grossman is a co-founder of the Alliance for a Stronger FDA and currently serves as the organization’s Executive Director. The Alliance is a multi-stakeholder, 150-member coalition that advocates for increased resources for the FDA.

Mr. Grossman also serves on the Board of Directors of the National Organization for Rare Disorders (NORD).